AMBROSINO, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 1.153
EU - Europa 995
AS - Asia 235
AF - Africa 60
OC - Oceania 8
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.465
Nazione #
US - Stati Uniti d'America 1.139
IE - Irlanda 311
RU - Federazione Russa 114
CN - Cina 112
IT - Italia 93
FI - Finlandia 82
AT - Austria 81
UA - Ucraina 80
SG - Singapore 72
SE - Svezia 63
CI - Costa d'Avorio 60
DE - Germania 59
BE - Belgio 46
GB - Regno Unito 30
IN - India 22
CA - Canada 12
FR - Francia 9
IR - Iran 9
NL - Olanda 7
AU - Australia 6
EU - Europa 5
JP - Giappone 5
CL - Cile 3
ES - Italia 3
GR - Grecia 3
AR - Argentina 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
HK - Hong Kong 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RO - Romania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BR - Brasile 1
CH - Svizzera 1
CR - Costa Rica 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
TR - Turchia 1
Totale 2.465
Città #
Dublin 308
Chandler 240
Jacksonville 170
Ann Arbor 92
Vienna 81
Helsinki 69
New York 64
Abidjan 60
Singapore 47
Woodbridge 47
Brussels 46
Wilmington 44
Beijing 40
San Mateo 33
Princeton 28
Boardman 27
Dearborn 22
Rome 22
Molise 16
Los Angeles 11
Hefei 10
Nanjing 10
Kunming 9
Redwood City 9
Houston 8
London 7
Toronto 7
Mountain View 6
Naples 6
Napoli 6
Norwalk 6
Ashburn 5
Dallas 5
Augusta 4
Clearwater 4
Pune 4
Roseto Degli Abruzzi 4
Sacramento 4
Seattle 4
Shenyang 4
Stockholm 4
Athens 3
Baotou 3
Falkenstein 3
Gaillimh 3
Jinan 3
Lappeenranta 3
Milan 3
Mumbai 3
Ottawa 3
San Francisco 3
Tokyo 3
Wuhan 3
Yekaterinburg 3
Andover 2
Auckland 2
Berlin 2
Birmingham 2
Cassino 2
Chengdu 2
Guangzhou 2
Haikou 2
Hebei 2
Hong Kong 2
Leawood 2
Moscow 2
Noicattaro 2
Paris 2
Pescara 2
Quito 2
Redmond 2
Saint-maur-des-fossés 2
San Vito Chietino 2
St Petersburg 2
Taiyuan 2
Warsaw 2
Zhengzhou 2
Almaty 1
Almere Stad 1
Amman 1
Amsterdam 1
Apo 1
Ardabil 1
Ashgabat 1
Auburn Hills 1
Bangalore 1
Barcelona 1
Bisaccia 1
Bloomington 1
Borås 1
Boston 1
Calvisano 1
Chicago 1
Chisinau 1
Colombo 1
Copenhagen 1
Cormano 1
Delhi 1
Dongguan 1
Evanston 1
Totale 1.701
Nome #
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 135
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 112
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 112
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 112
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 101
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 101
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 101
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 98
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine 98
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 98
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators 95
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 95
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 94
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 94
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 90
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 89
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 85
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 85
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+Channel Gating 84
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 83
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 76
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 74
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 57
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 57
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 56
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 51
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 48
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 45
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 42
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 37
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 17
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties 15
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 15
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 13
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel 9
Totale 2.574
Categoria #
all - tutte 12.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020274 0 0 0 0 22 29 87 40 48 17 4 27
2020/2021246 12 22 1 35 35 26 36 3 29 5 38 4
2021/2022209 4 29 1 8 22 14 7 18 42 26 22 16
2022/2023886 116 50 6 101 65 78 1 37 377 31 18 6
2023/2024220 36 27 9 3 5 68 5 6 10 5 7 39
2024/2025329 67 20 93 26 123 0 0 0 0 0 0 0
Totale 2.574